Franklin Resources’s Cidara Therapeutics CDTX Stock Holding History

Franklin Resources’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,650	Closed	-$2.79M	–	3176
2025 Q4	$2.79M	Buy	12,650 +1,269	+11%	+$205K	﹤0.01%	1652
2025 Q3	$1.09M	Buy	+11,381	New	+$726K	﹤0.01%	2054

Franklin Resources's CDTX Position: Q1 2026 in Review

Franklin Resources sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 12,650 shares — an estimated $2.79M sold.

Franklin Resources first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $2.79M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Franklin Resources reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Franklin Resources sold 12,650 Cidara Therapeutics shares in Q1 2026, an estimated $2.79M.
Franklin Resources first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Franklin Resources's Cidara Therapeutics position peaked at $2.79M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.